Skip to main content
Premium Trial:

Request an Annual Quote

New Swiss Vaccine Research Institute to Use EPFL's Omics Technologies

NEW YORK (GenomeWeb News) - The Swiss Institute for Vaccine Research, scheduled to open today, will use genomics, proteomics, molecular screening, and imaging technologies provided by the Ecole Polytechnique Fédérale de Lausanne.
 
EPFL will use these technologies to study virology, microbiology, and vectorology and develop new high-flow and automated immunology tests.
 
The primary goal of the SIVR is to develop an immunology, microbiology, and vaccine research laboratory platform intended to encourage collaborative research in the fields of HIV, malaria, tuberculosis, and cancer vaccine development.
 
Other institutes involved in the SIVR include the Centre Hospitalier Universitaire Vaudois, the Faculty of Biology and Medicine at the University of Lausanne, the Institute for Biomedical Research in Bellinzona, and the Ludwig Institute for Cancer Research.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.